Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13959 | 738 | 37.1 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
370 | 16580 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIAZENIUMDIOLATE | Author keyword | 48 | 76% | 5% | 34 |
2 | JS K | Author keyword | 44 | 100% | 2% | 16 |
3 | DIAZENIUMDIOLATES | Author keyword | 32 | 78% | 3% | 21 |
4 | COMPARAT CARCINOGENESIS | Address | 16 | 17% | 12% | 85 |
5 | DRUG DESIGN SECT | Address | 11 | 78% | 1% | 7 |
6 | CHEM SECT | Address | 9 | 15% | 8% | 59 |
7 | V PYRRO NO | Author keyword | 6 | 100% | 1% | 4 |
8 | NITRIC OXIDE RELEASE | Author keyword | 4 | 26% | 2% | 14 |
9 | ALKOXY NNO AZOXY COMPOUNDS | Author keyword | 3 | 100% | 0% | 3 |
10 | CATALYTIC GENERATION | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIAZENIUMDIOLATE | 48 | 76% | 5% | 34 | Search DIAZENIUMDIOLATE | Search DIAZENIUMDIOLATE |
2 | JS K | 44 | 100% | 2% | 16 | Search JS+K | Search JS+K |
3 | DIAZENIUMDIOLATES | 32 | 78% | 3% | 21 | Search DIAZENIUMDIOLATES | Search DIAZENIUMDIOLATES |
4 | V PYRRO NO | 6 | 100% | 1% | 4 | Search V+PYRRO+NO | Search V+PYRRO+NO |
5 | NITRIC OXIDE RELEASE | 4 | 26% | 2% | 14 | Search NITRIC+OXIDE+RELEASE | Search NITRIC+OXIDE+RELEASE |
6 | ALKOXY NNO AZOXY COMPOUNDS | 3 | 100% | 0% | 3 | Search ALKOXY+NNO+AZOXY+COMPOUNDS | Search ALKOXY+NNO+AZOXY+COMPOUNDS |
7 | CATALYTIC GENERATION | 3 | 100% | 0% | 3 | Search CATALYTIC+GENERATION | Search CATALYTIC+GENERATION |
8 | N DIAZENIUMDIOLATES | 3 | 100% | 0% | 3 | Search N+DIAZENIUMDIOLATES | Search N+DIAZENIUMDIOLATES |
9 | PABA NO | 3 | 100% | 0% | 3 | Search PABA+NO | Search PABA+NO |
10 | NONOATE | 3 | 33% | 1% | 7 | Search NONOATE | Search NONOATE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | THROMBORESISTANT | 47 | 86% | 3% | 24 |
2 | JS K | 28 | 68% | 3% | 25 |
3 | ANTICANCER LEAD | 17 | 100% | 1% | 8 |
4 | CONTROLLED BIOLOGICAL RELEASE | 16 | 49% | 3% | 24 |
5 | SOL GEL MICROARRAYS | 15 | 88% | 1% | 7 |
6 | NITROGENII OXIDE | 14 | 65% | 2% | 13 |
7 | CATALYTIC GENERATION | 11 | 54% | 2% | 14 |
8 | SOL GELS | 8 | 30% | 3% | 24 |
9 | PRIMARY S NITROSOTHIOLS | 8 | 100% | 1% | 5 |
10 | PYRRO NO | 8 | 100% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Nitric oxide release: Part II. Therapeutic applications | 2012 | 93 | 90 | 42% |
Nitric oxide release: Part I. Macromolecular scaffolds | 2012 | 62 | 77 | 55% |
Nitric oxide release: Part III. Measurement and reporting | 2012 | 66 | 58 | 47% |
Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contactincy medical devices | 2005 | 143 | 54 | 56% |
Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives | 2002 | 207 | 124 | 57% |
Nitric Oxide Donors for Cardiovascular Implant Applications | 2013 | 18 | 103 | 42% |
Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances | 2011 | 21 | 53 | 68% |
Nanotechnology as a therapeutic tool to combat microbial resistance | 2013 | 48 | 53 | 17% |
''NONOates'' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: Convenient nitric oxide dosage forms | 1996 | 436 | 8 | 63% |
Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): Emerging commercial opportunities | 2005 | 64 | 89 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMPARAT CARCINOGENESIS | 16 | 17% | 12% | 85 |
2 | DRUG DESIGN SECT | 11 | 78% | 0.9% | 7 |
3 | CHEM SECT | 9 | 15% | 8.0% | 59 |
4 | CHEM SECT COMPARAT CARCINOGENESIS | 1 | 100% | 0.3% | 2 |
5 | HISTOL MICROBIOL BIOMED TECHNOL | 1 | 33% | 0.3% | 2 |
6 | CHEM SYNTH ANAL | 1 | 21% | 0.4% | 3 |
7 | ADV MAT TECHNOLEDUC MINIST | 1 | 50% | 0.1% | 1 |
8 | BASI PROGRAM | 1 | 50% | 0.1% | 1 |
9 | KATEDRA KLIN CHOROB WEWNETRZNYCH NADCISNIENIA T | 1 | 50% | 0.1% | 1 |
10 | LEVINE SCI B 120 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000176233 | GRP IMMUNOBIOL//HUMAN NUTR METAB DIS LIM 25//EXPT ONCOL LIM 24 |
2 | 0.0000147950 | S NITROSOTHIOLS//S NITROSYLATION//S NITROSOGLUTATHIONE |
3 | 0.0000118789 | RUTHENIUM NITROSYL//RUTHENIUM NITROSYL COMPLEXES//NITROSYL |
4 | 0.0000112326 | NO ASPIRIN//NITROASPIRIN//NCX 4016 |
5 | 0.0000106474 | COLLAGENOUS PROTEIN BIOSYNTHESIS//NOS3//IMMUNOL IMMUNOTHER IE CANC |
6 | 0.0000106099 | NITROXYL//ANGELIS SALT//PILOTYS ACID |
7 | 0.0000102145 | PORPHYRINIC SENSOR//CELLULAR BIOSENSING//IRON DITHIOCARBAMATE COMPLEXES |
8 | 0.0000087325 | FK409//ANTITHROMBOTIC PROPERTIES//ANTITHROMBOTIC ACTIVITIES |
9 | 0.0000081588 | DERMCIDIN ISOFORM 2//ACUTE ISCHEMIC HEART DISEASE//GEA 3175 |
10 | 0.0000065571 | CALVATIC ACID AND DERIVATIVES//2 THIOUREIDOBENZOXAZOLE//CATTEDRA MICROBIOL CLIN 1 |